Gain Therapeutics (GANX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Gain Therapeutics (GANX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Gain Therapeutics

· GANX

Dashboard

Financials

Ratios

Valuation

Statistics

73.321 M

+2.98%

General

Market Cap: $73.32M
Enterprise Value: $61.32M
Shares Outstanding: 42,650,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -130.37%
ROE: -161.58%
ROIC: -157.82%
Current Ratio: 4.36
Debt-to-Equity: 0.05
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 6.53
EV/EBITDA: -3.21

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $19.29M
Operating Income: -$19.29M
Net Profit: -$20.11M

Balance Sheet

Cash and Equivalents: $13.08M
Working Capital: $11.54M
Total Assets: $15.42M
Net Debt: -$12.47M
Total Liabilities: $4.13M
Total Equity: $11.29M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$18.95M
Cash Flow from Investing: —
Cash Flow from Financing: $25.35M
Free Cash Flow: -$18.95M
Capital Expenditures: $10